HAI
CLBT icon

Hennessy Advisors Inc’s Cellebrite CLBT Stock Holding History

Hennessy Advisors Inc’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,169
Closed -$82.7K – 298
2025
Q2 		$82.7K Buy
+5,169
New +$92.1K ﹤0.01% 336
2024
Q4 		– Sell
-10,741
Closed -$181K – 309
2024
Q3 		$181K Sell
10,741
-730
-6% -$10.8K 0.01% 295
2024
Q2 		$137K Sell
11,471
-2,195
-16% -$24.5K 0.01% 297
2024
Q1 		$151K Sell
13,666
-1,474
-10% -$15K 0.01% 283
2023
Q4 		$131K Buy
+15,140
New +$118K 0.01% 295

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Hennessy Advisors Inc's CLBT Position: Q3 2025 in Review

Hennessy Advisors Inc sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 5,169 shares — an estimated $82.7K sold.

Hennessy Advisors Inc first reported a position in CLBT in Q4 2023 and held it in 5 quarters. The position peaked at $181K in Q3 2024. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Hennessy Advisors Inc reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Hennessy Advisors Inc sold 5,169 Cellebrite shares in Q3 2025, an estimated $82.7K.
  • Hennessy Advisors Inc first reported a position in Cellebrite in Q4 2023 and held it in 5 quarters.
  • Hennessy Advisors Inc's Cellebrite position peaked at $181K in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Hennessy Advisors Inc's 13F filing for Q3 2025, filed 20 Oct 2025.